Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Neurocrine Clinical Site, New York

Neurocrine Clinical Site, The Bronx

Neurocrine Clinical Site, Durham

Neurocrine Clinical Site, Charleston

Neurocrine Clinical Site, Gulf Breeze

Neurocrine Clinical Site, Orlando

Neurocrine Clinical Site, Orlando

Neurocrine Clinical Site, Hialeah

Neurocrine Clinical Site, Boca Raton

Neurocrine Clinical Site, Tampa

Neurocrine Clinical Site, St. Petersburg

Neurocrine Clinical Site, Mason

Neurocrine Clinical Site, Ann Arbor

Neurocrine Clinical Site, Bloomfield Hills

Neurocrine Clinical Site, Iowa City

Neurocrine Clinical Site, Naperville

Neurocrine Clinical Site, Chicago

Neurocrine Clinical Site, St Louis

Neurocrine Clinical Site, Leawood

Neurocrine Clinical Site, Lincoln

Neurocrine Clinical Site, Oklahoma City

Neurocrine Clinical Site, Dallas

Neurocrine Clinical Site, Houston

Neurocrine Clinical Site, Houston

Neurocrine Clinical Site, San Antonio

Neurocrine Clinical Site, Sun City

Neurocrine Clinical Site, Santa Clarita

Neurocrine Clinical Site, San Diego

Neurocrine Clinical Site, Santa Ana

Neurocrine Clinical Site, Anaheim

Neurocrine Clinical Site, Everett

Neurocrine Clinical Site, Tacoma

Neurocrine Clinical Site, New Haven

Neurocrine Clinical Site, Nashua

Neurocrine Clinical Site, Mount Arlington

Neurocrine Clinical Site, Voorhees Township

Neurocrine Clinical Site, San Juan